‘A Pivotal Moment’

‘A Pivotal Moment’

Global equities found quite a bit to like in trade news and economic data out of Asia on Monday. Stocks were buoyant after activity data for October suggested China's economic recovery is on track, while a new regional trade deal covering AsiaPac suggests multilateralism isn't dead after all. Just before 7 AM in the US, Moderna released preliminary data for its COVID vaccine. As expected, the news was good. In fact, Moderna's results were even better than Pfizer's, at least on a quick read. Va
Subscribe or log in to read the rest of this content.

2 thoughts on “‘A Pivotal Moment’

  1. Success rates on a preliminary basis over 90% is better than expected. This is good news, but we are going to be dealing with covid for an extened time even so. Good luck to all.

Speak your mind

This site uses Akismet to reduce spam. Learn how your comment data is processed.